Jenner Institute

{{Short description|Vaccine research institute in Oxford}}

{{Use dmy dates|date=November 2020}}

{{Use British English|date=November 2020}}

{{Infobox institute

| image = Jenner_Institute_Logo.png

| established = {{start date and age|2005|11}}

| head_label = Director

| head = Adrian Hill

| key_people = Sarah Gilbert
Helen McShane

| parent = University of Oxford

| budget =

| remarks =

| name = The Jenner Institute

| location = Old Road Campus Research Building

| address = Old Road Campus Research Building (ORCRB), Roosevelt Drive, Oxford OX3 7DQ, UK

| city = Oxford

| country = United Kingdom

| staff = 100

| website = {{Official URL}}

| former_name = Edward Jenner Institute for Vaccine Research

| coordinates = {{coord|51.7519293|-1.2163045|dim:500_region:GB-OXF_type:landmark|display=inline,title}}

}}

The Jenner Institute is a research institute on the Old Road Campus in Headington, east Oxford, England. It was formed in November 2005 through a partnership between the University of Oxford and the UK Institute for Animal Health.{{cite web | url=https://www.ndm.ox.ac.uk/the-jenner-institute | title=The Jenner Institute | work=Health Check | publisher=Nuffield Department of Medicine, University of Oxford | location=UK | access-date=17 April 2020 | archive-date=27 May 2020 | archive-url=https://web.archive.org/web/20200527013440/https://www.ndm.ox.ac.uk/the-jenner-institute | url-status=dead }} It is associated with the Nuffield Department of Medicine, in the Medical Sciences Division of Oxford University. The institute receives charitable support from the Jenner Vaccine Foundation.{{Twitter|JennerInstitute}}

The institute is led by Prof. Adrian Hill.{{cite web| url=https://www.bbc.co.uk/programmes/p02st6qs | title=Preparing for Future Epidemics | work=Health Check | publisher=BBC | location=UK | date=10 June 2015 | access-date=17 April 2020 }} The institute develops vaccines and carries out clinical trials for diseases including malaria, tuberculosis (vaccine MVA85A), ebola, and MERS-Coronavirus.{{cite news |url=https://www.bbc.co.uk/news/health-29230157 |title=Ebola vaccine trial begins |work=BBC News |date=17 September 2014}}{{cite web |url=https://www.ndm.ox.ac.uk/principal-investigators/researcher/helen-mcshane |title=Helen McShane |publisher=ndm.ox.ac.uk}}

In 2020, the institute successfully developed the Oxford–AstraZeneca COVID-19 vaccine, in a project backed by private companies including Oxford Sciences Innovation, Google Ventures, and Sequoia Capital, among others.{{cite web|date=23 November 2020|title=The Backstory: Vaccitech and its role in co-inventing the Oxford COVID-19 vaccine|url=https://www.oxfordsciencesinnovation.com/news/the-backstory-vaccitech-and-its-role-in-co-inventing-the-oxford-covid-19-vaccine/|access-date=25 March 2021|publisher=Oxford Sciences Innovation|archive-date=1 May 2021|archive-url=https://web.archive.org/web/20210501164556/https://www.oxfordsciencesinnovation.com/news/the-backstory-vaccitech-and-its-role-in-co-inventing-the-oxford-covid-19-vaccine/|url-status=live}} When developed, the UK government backed trials, purchased 100{{nbsp}}million doses, and encouraged Oxford to work with AstraZeneca, a company based in Europe, instead of Merck & Co., a US-based company; while the US gave {{US$|1.2bn}} of government funding in return for 300 million doses.{{cite news | title = The Oxford vaccine: the trials and tribulations of a world-saving jab | date = 26 June 2021 | url = https://www.theguardian.com/world/2021/jun/26/the-oxford-vaccine-the-trials-and-tribulations-of-a-world-saving-jab | work = The Guardian | access-date = 27 June 2021 | archive-date = 27 June 2021 | archive-url = https://web.archive.org/web/20210627114711/https://www.theguardian.com/world/2021/jun/26/the-oxford-vaccine-the-trials-and-tribulations-of-a-world-saving-jab | url-status = live }}{{Cite web|vauthors=Keown C|title=U.S. gives AstraZeneca $1.2 billion to fund Oxford University coronavirus vaccine — America would get 300 million doses beginning in October|url=https://www.marketwatch.com/story/us-gives-astrazeneca-12-billion-to-fund-oxford-university-coronavirus-vaccine-securing-300-million-doses-for-country-from-october-2020-05-21|access-date=30 March 2021|website=MarketWatch|archive-date=26 January 2021|archive-url=https://web.archive.org/web/20210126045250/https://www.marketwatch.com/story/us-gives-astrazeneca-12-billion-to-fund-oxford-university-coronavirus-vaccine-securing-300-million-doses-for-country-from-october-2020-05-21|url-status=live}} It collaborated with Italy's Advent Srl (part of the IRBM Group) on the development{{cite web | url=https://www.irbm.com/news/the-jenner-institute-signs-an-agreement-with-advent-to-develop-a-novel-coronavirus-vaccine/ | title=The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine | publisher=IRBM | access-date=18 April 2020 | archive-date=19 January 2021 | archive-url=https://web.archive.org/web/20210119190244/https://www.irbm.com/news/the-jenner-institute-signs-an-agreement-with-advent-to-develop-a-novel-coronavirus-vaccine/ | url-status=dead }} and Germany's Merck Group on the manufacture of the COVID-19 vaccine.{{cite press release |url=https://www.merckgroup.com/en/news/jenner-milestone-covid-19-vaccine-manufacturing-14-04-2020.html |title=Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing |publisher=Merck Group |access-date=17 April 2020 }} Vaccinologist Dame Sarah Gilbert was one of the leading scientists involved in the development.{{cite journal| pmid=32305089 |pmc=7162644 | title=Sarah Gilbert: carving a path towards a COVID-19 vaccine | journal=The Lancet | volume=395 | number=10232 | page=1247 | first=Richard | last=Lane | date= 2020 | doi=10.1016/S0140-6736(20)30796-0 }}{{cite web| url=https://www.bbc.co.uk/programmes/p089xqrl | title=Prof Sarah Gilbert: Coronavirus vaccine trials to start within days | work=The Andrew Marr Show | publisher=BBC One | location=UK | date=19 April 2020 | access-date=19 April 2020 }}

The institute is named after the English physician and immunization pioneer Edward Jenner (1749–1823), who was a major contributor to the development of the smallpox vaccine.{{Cn|date=June 2021}}

__TOC__